期刊文献+

解热镇痛药的发展概况 被引量:7

Advance in Non-steroidal Antiinflammatory Drugs
下载PDF
导出
摘要 解热镇痛类药物包括传统的非甾体类抗炎药(COX-1抑制剂)、非传统的非甾体类抗炎药(COX-2抑制剂和一氧化氮释放型NSAIDs)。文章分析其国内外市场状况,并指出临床应用所存在的问题。总结了常用解热镇痛药的不良反应,提出了应用时应注意的事项。预计在今后的一段时期内,研究COX-2选择性抑制剂,发现新结构类型的高活性化合物仍是主攻方向,而且开发NO-NSAIDs也会成为降低NSAIDs的不良反应,增加其疗效的途径之一。 NSAIDs (nonsteroidal anniin flammatory drugs) include traditional NSAIDs (COX-1 inhibitor) and non-traditional NSAIDs(COX-2 inhibitor and NO-NSAIDs). The article analyzed its domestic and international market situation, and pointed out the problems in public application of NSAIDs, summed up their adverse effects, and putted forward many noticeable things during the applying. In many years forward, exploiting COX-2 inhibitor and discovering higher-efficiency compound will be the main direction. NO-NSAIDs will also be the developing way.
出处 《动物医学进展》 CSCD 2006年第6期45-49,共5页 Progress In Veterinary Medicine
关键词 解热镇痛药 发展概况 不良反应 高活性化合物 NSAIDs development ADRs
  • 相关文献

参考文献20

二级参考文献111

  • 1陈庆明,康毅.抗炎免疫药物的研究进展[J].天津药学,2004,16(5):64-66. 被引量:1
  • 2郝文利,李培锋.解热镇痛药的发展概况[J].动物医学进展,2006,27(6):45-49. 被引量:7
  • 3[1]Lichtenstein D, Syngal S, Wlfe MM. Non-steroidal antiinflammatory drugs and the gastrointestinal tract. Arthritis Rherm,1995;38:1:5~18.
  • 4[2]Bjarnason I, Macpherson A, Somasundaram S, et al. Lower bowel toxicity of non-steroidal anti-inflammatory drugs. Lewis A: Non-steroidal Anti-Inflammatory Drugs, Mechanisms and Clinical Uses. New York: NY, Marcel Dekker, 1994;145~157.
  • 5[3]Marie R, Griffin, MD. Epidemiology of non-steroidal antiinflammatory drug-associated gastrointestinal injury. Am J Med.1998;104: 23~28.
  • 6[4]Fujiwara Y, Schmassman A, Arakawa T, et al. Indomethacin interferes with epidermal growth factor binding and proliferative response of KATO Ⅲ cells. Digestion, 1995;56:364~369.
  • 7[5]Henry D, Robertson J. Non-steroidal anti-inflammatory drugs and peptic ulcer hospitalization rates in New South Wales.Gastroenterology. 1993; 104:1083~ 1091.
  • 8[6]Fries JF, Williams CA, Michel BA et al. Nonsteroidal antiinflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med, 1991 ;91:213 ~222.
  • 9[7]Gutthamm SP, García LA, Raiford DS. Individual nonsteroidal anti-inflammatory drugs and the risk of hospitalization for upper gastrointestinal bleeding and perforation in saskatche wan: a nested case-control study. Pharmacoepidemiol Drug Safety. 1994;3:S63.
  • 10[8]Loeb DS, Talley NJ, Ahlquist DA, et al. Long-term non-steroidal anti-inflammatorydrug use and gastroduodenal injury: the role of Helicobacter pylori. Gastroenterology, 1992;102 :1899~1905.

共引文献100

同被引文献66

引证文献7

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部